Trader consensus favoring "No" at 95.3% implied probability stems from ongoing low-level endemic circulation of SARS-CoV-2, with global test positivity rates near 1-4% and case/death counts far below pandemic thresholds through mid-2026. WHO and CDC surveillance data show declining trends since late 2025, no variants under monitoring exhibiting enhanced transmissibility or virulence, and the virus behaving as a seasonal respiratory pathogen alongside others rather than driving exponential outbreaks. Historical zoonotic spillover risks from bat or camel reservoirs persist but lack evidence of imminent high-impact emergence. Realistic shifts could arise from rapid evolution of an immune-escape variant or undetected novel coronavirus introduction, though current model consensus and reporting timelines through year-end limit near-term probability of such events.